• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多功能杂化纳米粒子作为磁递药系统用于针对乳腺癌细胞 HER2 基因的 siRNA 靶向治疗。

Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.

机构信息

GEIMM, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

GEIMM, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis, SC, Brazil; PGMAT, Department of Mechanical Engineering, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

出版信息

Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110555. doi: 10.1016/j.msec.2019.110555. Epub 2019 Dec 14.

DOI:10.1016/j.msec.2019.110555
PMID:32228895
Abstract

Breast cancer is a major cause of death among women worldwide. Resistance to conventional therapies has been observed in HER2-positive breast cancer patients, indicating the need for more effective treatments. Small interfering RNA (siRNA) therapy is an attractive strategy against HER2-positive tumors, but its success depends largely on the efficient delivery of agents to target tissues. In this study, we prepared a magnetic hybrid nanostructure composed of iron oxide nanoparticles coated with caffeic acid and stabilized by layers of calcium phosphate and PEG-polyanion block copolymer for incorporation of siRNA. Transmission electron microscopy images showed monodisperse, neutrally charged compact spheres sized <100 nm. Dynamic light scattering and nanoparticle tracking analysis revealed that the nanostructure had an average hydrodynamic diameter of 130 nm. Nanoparticle suspensions remained stable over 42 days of storage at 4 and 25 °C. Unloaded caffeic acid-magnetic calcium phosphate (Caf-MCaP) nanoparticles were not cytotoxic, and loaded nanoparticles were successfully taken up by the HER2-positive breast cancer cell line HCC1954, even more so under magnetic guidance. Nanoparticles escaped endosomal degradation and delivered siRNA into the cytoplasm, inducing HER2 gene silencing.

摘要

乳腺癌是全球女性死亡的主要原因之一。HER2 阳性乳腺癌患者对常规治疗产生耐药性,表明需要更有效的治疗方法。小干扰 RNA(siRNA)治疗是针对 HER2 阳性肿瘤的一种有吸引力的策略,但它的成功在很大程度上取决于将药物有效递送到靶组织。在这项研究中,我们制备了一种由氧化铁纳米粒子组成的磁性杂化纳米结构,这些纳米粒子被咖啡酸包覆,并由磷酸钙层和聚乙二醇-聚阴离子嵌段共聚物稳定,用于掺入 siRNA。透射电子显微镜图像显示出单分散的、带中性电荷的、小于 100nm 的紧凑球体。动态光散射和纳米颗粒跟踪分析表明,该纳米结构的平均水动力直径为 130nm。纳米颗粒悬浮液在 4°C 和 25°C 下储存 42 天仍保持稳定。未负载的咖啡酸-磁性磷酸钙(Caf-MCaP)纳米颗粒没有细胞毒性,负载的纳米颗粒被 HER2 阳性乳腺癌细胞系 HCC1954 成功摄取,在磁场引导下摄取更多。纳米颗粒逃脱了内体降解,并将 siRNA 递送到细胞质中,诱导 HER2 基因沉默。

相似文献

1
Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.多功能杂化纳米粒子作为磁递药系统用于针对乳腺癌细胞 HER2 基因的 siRNA 靶向治疗。
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110555. doi: 10.1016/j.msec.2019.110555. Epub 2019 Dec 14.
2
Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells.用于体外向乳腺癌细胞递送 siRNA 的磁响应性杂化纳米颗粒。
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:1182-1190. doi: 10.1016/j.msec.2019.02.026. Epub 2019 Feb 10.
3
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.长期 HER2 siRNA 纳米颗粒治疗后 HER2 阳性乳腺癌细胞中获得性耐药的缺失。
PLoS One. 2018 Jun 7;13(6):e0198141. doi: 10.1371/journal.pone.0198141. eCollection 2018.
4
Her2/neu small interfering RNA delivered in culture by a streptavidin nanoparticle.载 Her2/neu 小分子干扰 RNA 的链霉亲和素纳米颗粒在培养中传递。
Curr Drug Deliv. 2012 Jul;9(4):431-6. doi: 10.2174/156720112801323035.
5
Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.用于特异性递送 siRNA 的磁性纳米载体:乳腺癌细胞主动靶向对下调效率的贡献。
Int J Pharm. 2019 Oct 5;569:118572. doi: 10.1016/j.ijpharm.2019.118572. Epub 2019 Jul 26.
6
HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer.HER2 siRNA 促进基因沉默联合多柔比星递送:双重响应纳米平台消除乳腺癌。
ACS Appl Mater Interfaces. 2024 May 22;16(20):25710-25726. doi: 10.1021/acsami.4c02532. Epub 2024 May 13.
7
ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.ScFv 修饰的 PEG-PLA 基纳米粒增强 siRNA 递送至 Her2⁺乳腺癌。
Adv Healthc Mater. 2014 Nov;3(11):1792-803. doi: 10.1002/adhm.201400037. Epub 2014 Jun 20.
8
Short interfering RNA delivered by a hybrid nanoparticle targeting VEGF: Biodistribution and anti-tumor effect.载有靶向 VEGF 的杂交纳米颗粒的短干扰 RNA:生物分布和抗肿瘤作用。
Biochim Biophys Acta Gen Subj. 2021 Sep;1865(9):129938. doi: 10.1016/j.bbagen.2021.129938. Epub 2021 May 29.
9
Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo.抗HER2功能化氧化石墨烯作为生存素小干扰RNA递送载体在体外和体内均能抑制乳腺癌生长。
Drug Des Devel Ther. 2018 Sep 7;12:2841-2855. doi: 10.2147/DDDT.S169430. eCollection 2018.
10
Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.用于治疗乳腺癌的适配体功能化杂化纳米颗粒。
Eur J Pharm Biopharm. 2017 May;114:108-118. doi: 10.1016/j.ejpb.2017.01.011. Epub 2017 Jan 25.

引用本文的文献

1
Smart Nanoarchitectures for Precision RNA Delivery: Harnessing Endogenous and Exogenous Stimuli in Cancer Treatment.用于精准RNA递送的智能纳米结构:在癌症治疗中利用内源性和外源性刺激
Theranostics. 2025 Jul 2;15(15):7747-7778. doi: 10.7150/thno.112492. eCollection 2025.
2
Magnetic-vortex nanodonuts enhance ferroptosis effect of tumor ablation through an imaging-guided hyperthermia/radiosensitization strategy.磁性涡旋纳米甜甜圈通过成像引导的热疗/放射增敏策略增强肿瘤消融的铁死亡效应。
iScience. 2024 Jul 18;27(10):110533. doi: 10.1016/j.isci.2024.110533. eCollection 2024 Oct 18.
3
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy.
用于癌症免疫治疗中精确靶向药物递送和增强治疗效果的工程纳米颗粒。
Acta Pharm Sin B. 2024 Aug;14(8):3432-3456. doi: 10.1016/j.apsb.2024.05.010. Epub 2024 May 13.
4
Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery.磁性氧化铁纳米粒子的表面工程用于乳腺癌诊断和药物输送。
Int J Nanomedicine. 2024 Aug 17;19:8437-8461. doi: 10.2147/IJN.S477652. eCollection 2024.
5
Hybrid Nanoparticles for Cancer Theranostics: A Critical Review on Design, Synthesis, and Multifunctional Capabilities.用于癌症诊疗的杂化纳米颗粒:关于设计、合成及多功能能力的批判性综述
Curr Med Chem. 2024 Jun 24. doi: 10.2174/0109298673309011240606095639.
6
Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review.乳腺癌纳米颗粒药物递送系统的当前观点与趋势:文献计量分析与综述
Front Bioeng Biotechnol. 2023 Sep 12;11:1253048. doi: 10.3389/fbioe.2023.1253048. eCollection 2023.
7
Recent Advances in the Development of Drug Delivery Applications of Magnetic Nanomaterials.磁性纳米材料药物递送应用发展的最新进展
Pharmaceutics. 2023 Jul 3;15(7):1872. doi: 10.3390/pharmaceutics15071872.
8
Oral delivery of RNAi for cancer therapy.癌症治疗的 RNAi 口服递送。
Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27.
9
Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer.通过绿色化学合成的超顺磁性氧化铁纳米粒子,有望用于治疗乳腺癌。
Molecules. 2023 Mar 3;28(5):2343. doi: 10.3390/molecules28052343.
10
Effects of siRNA-mediated Silencing of ERBB2, IGF-1R, and ITGB1 in HER2-positive Breast Cancer Cells.小干扰RNA介导的ERBB2、IGF-1R和ITGB1基因沉默对HER2阳性乳腺癌细胞的影响
Cancer Diagn Progn. 2023 Mar 3;3(2):183-188. doi: 10.21873/cdp.10199. eCollection 2023 Mar-Apr.